2026年2月24日，北京同仁堂制药厂收到加拿大卫生部核发的《产品许可证（三类）》，儿感清口服液、锁阳固精丸、人参健脾丸、大黄䗪虫丸正式获得加拿大产品注册。注册主体为同仁堂旗下分支机构，注册地为加拿大。此举系同仁堂推进中医药国际化的重要进展。但上述产品在加销售尚需通过生产场地GMP认证等后续审批，存在不确定性。本次注册不构成对公司近期经营业绩的重大影响。
Source Link2026年2月24日，北京同仁堂制药厂收到加拿大卫生部核发的《产品许可证（三类）》，儿感清口服液、锁阳固精丸、人参健脾丸、大黄䗪虫丸正式获得加拿大产品注册。注册主体为同仁堂旗下分支机构，注册地为加拿大。此举系同仁堂推进中医药国际化的重要进展。但上述产品在加销售尚需通过生产场地GMP认证等后续审批，存在不确定性。本次注册不构成对公司近期经营业绩的重大影响。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.